Background Community-based clinical trials of the inhaled corticosteroid budesonide in
early COVID-19 have shown improved patient outcomes. We aimed to understand the …

Current treatments fail to modify the underlying pathophysiology and disease progression of
chronic obstructive pulmonary disease (COPD), necessitating alternative therapies. Here …

Africa accounts for 1.5% of the global coronavirus disease 2019 (COVID-19) cases and
2.7% of deaths, but this low incidence has been partly attributed to the limited testing …

Background It is widely reported that the SARS-CoV-2 Omicron variant has resulted in high
number of cases, but relatively low incidence of severe disease and deaths, compared to the …

The burden of severe Covid-19 has been relatively low in sib-Saharan Africa compared to
Europe and the Americas. However, SARS-CoV-2 sero-prevalence data has demonstrated …

Data from much of Africa are still scarce on the clinical characteristics, outcomes of
treatment, and factors associated with disease severity and mortality of COVID-19. A cross …

Genomically informed clinical comparison of three epidemic waves of COVID-19 in Malawi
Page 1 1 Genomically informed clinical comparison of three epidemic waves of COVID-19 in …

Abstract Africa accounts for 1.5% of the global coronavirus disease 2019 (COVID-19) cases
and 2.7% of deaths, but this low incidence has been partly attributed to the limited testing …

People living with human immunodeficiency virus (PLHIV) on antiretroviral therapy (ART)
are reported to have three times higher carriage of Streptococcus pneumoniae than their …

The COVID-19 pandemic has highlighted the importance of international research
collaborations to quickly understand and successfully combat emerging and reemerging …